Q61R (p.Gln61Arg) variant of KRAS (GTPase KRas)
Q61R (p.Gln61Arg) in KRAS (GTPase KRas) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic in the context of Pyogenic granuloma. The available variant effect predictions contribute to a CATVariant prioritization score of 0.76 / 1. The record also includes population frequency data, experimental measurements, published literature, and structural context.
Q61R (p.Gln61Arg) variant details
- p.Gln61Arg
- Ensembl rs2141510086
- Pathogenic
- Pyogenic granuloma
- Missense
- Variant Prioritization Score for Impact Estimate 0.756
- REVEL 0.80
- ESM-1b 1.00
- AlphaMissense 0.99
- MetaLR 0.64
- MetaSVM 0.27
- CADD 26.90
- ClinVar: Pathogenic (Pyogenic granuloma)
- EBI: Pathogenic (in a colorectal cancer sample)
- UniProt: Pathogenic (in a colorectal cancer sample)
- Population evidence available
- Structural context available
- KRAS activity — DMSO (standardized): score 10.7
- Cited in: The consensus coding sequences of human breast and colorectal cancers. (PMID 16959974)
- Cited in: Structure of the MRAS-SHOC2-PP1C phosphatase complex. (PMID 35830882)